Manufacturers Life Insurance Company, The Immunome Inc. Transaction History
Manufacturers Life Insurance Company, The
- $102 Billion
- Q2 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Immunome Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 166,928 shares of IMNM stock, worth $2.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
166,928
Previous 109,686
52.19%
Holding current value
$2.4 Million
Previous $2.71 Million
25.42%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IMNM
# of Institutions
115Shares Held
43.4MCall Options Held
67.2KPut Options Held
65.9K-
Redmile Group, LLC San Francisco, CA4.89MShares$70.3 Million3.86% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.88MShares$55.8 Million1.66% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.88MShares$55.8 Million0.03% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$54.1 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X03.16MShares$45.5 Million0.02% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $174M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...